Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Work In Process (2022 - 2025)

Fortress Biotech (FBIO) has 4 years of Work In Process data on record, last reported at $435000.0 in Q1 2025.

  • For Q1 2025, Work In Process fell 45.96% year-over-year to $435000.0; the TTM value through Mar 2025 reached $435000.0, down 45.96%, while the annual FY2024 figure was $367000.0, 58.48% down from the prior year.
  • Work In Process reached $435000.0 in Q1 2025 per FBIO's latest filing, up from $367000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $2.7 million in Q2 2022 and bottomed at $26000.0 in Q3 2022.
  • Average Work In Process over 4 years is $707416.7, with a median of $495500.0 recorded in 2022.
  • Peak YoY movement for Work In Process: surged 1661.54% in 2023, then plummeted 70.19% in 2024.
  • A 4-year view of Work In Process shows it stood at $395000.0 in 2022, then skyrocketed by 123.8% to $884000.0 in 2023, then crashed by 58.48% to $367000.0 in 2024, then grew by 18.53% to $435000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $435000.0 in Q1 2025, $367000.0 in Q4 2024, and $296000.0 in Q2 2024.